08:38 AM EDT, 08/06/2024 (MT Newswires) -- Stevanato Group (STVN) reported Q2 adjusted earnings Tuesday of 0.09 euros ($0.098) per diluted share, down from 0.14 euros a year earlier.

Analysts polled by Capital IQ expected 0.10 euros.

Revenue for the quarter ended June 30 was 259.6 million euros, up from 255.3 million euros a year earlier.

Analysts surveyed by Capital IQ expected 255.5 million euros.

The drug delivery and diagnostic company said it now expects 2024 adjusted earnings of 0.48 to 0.50 euros per diluted share, down from its prior guidance of 0.51 to 0.55 euros. Analysts polled by Capital IQ expect 0.51 euros.

Revenue for the year is now anticipated in the range of 1.09 billion euros to 1.11 billion euros, compared with the previous outlook of 1.13 billion euros to 1.16 billion euros, the company said. Analysts surveyed by Capital IQ expect 1.12 billion euros.